Showing results (101-110 of 259) with videos related to
Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2013
Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutationsJames Chih-Hsin Yang, Vera Hirsh, Martin Schuler, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 4, 2014
Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancersHsiang-Fong Kao, I-Chun Chen, Chiun Hsu, et al.Lung Cancer (Amsterdam, Netherlands)|December 11, 2025
MAGELLAN arms B1 and B3: Durvalumab plus chemotherapy with and without oleclumab in treatment-naïve metastatic non-small-cell lung cancerByoung Chul Cho, Chaiyut Charoentum, Dong-Wan Kim, et al.Journal of Magnetic Resonance Imaging : JMRI|April 21, 2012
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatinYeun-Chung Chang, Chong-Jen Yu, Chung-Ming Chen, et al.Clinical Lung Cancer|August 5, 2019
Clinical Outcomes of Up-front Surgery Versus Surgery After Induction Chemotherapy for Thymoma and Thymic Carcinoma: A Retrospective StudyWei-Li Ma, Chia-Chi Lin, Feng-Ming Hsu, et al.Clinical and Translational Radiation Oncology|April 14, 2020
Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancerWen-Chi Yang, Feng-Ming Hsu, Yu-Hsuan Chen, et al.The Oncologist|May 26, 2019
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR InhibitorsJih-Hsiang Lee, Hsuan-Yu Chen, Feng-Ming Hsu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS)Fairooz Kabbinavar, Louis Fehrenbacher, John Hainsworth, et al.Plos One|November 19, 2013
Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor sizeZhong-Zhe Lin, Wen-Yi Shau, Chiun Hsu, et al.Oncotargets and Therapy|August 29, 2022
Sequential Afatinib and Osimertinib in Asian Patients with <i>EGFR</i> Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional StudiesSatoru Miura, Hyun Ae Jung, Shin Yup Lee, et al.Pageof 26